T. Rowe Price Associates’s Harvard Bioscience HBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,624
| Closed | -$8K | – | 3091 |
|
|
2025
Q1 | $8K | Hold |
12,624
| – | – | ﹤0.01% | 3023 |
|
|
2024
Q4 | $27K | Hold |
12,624
| – | – | ﹤0.01% | 2973 |
|
|
2024
Q3 | $34K | Hold |
12,624
| – | – | ﹤0.01% | 2965 |
|
|
2024
Q2 | $36K | Hold |
12,624
| – | – | ﹤0.01% | 2885 |
|
|
2024
Q1 | $54K | Buy |
+12,624
| New | +$54K | ﹤0.01% | 2863 |
|
|
2017
Q4 | – | Sell |
-28,200
| Closed | -$106K | – | 2568 |
|
|
2017
Q3 | $106K | Hold |
28,200
| – | – | ﹤0.01% | 2475 |
|
|
2017
Q2 | $72K | Hold |
28,200
| – | – | ﹤0.01% | 2508 |
|
|
2017
Q1 | $73K | Hold |
28,200
| – | – | ﹤0.01% | 2515 |
|
|
2016
Q4 | $86K | Hold |
28,200
| – | – | ﹤0.01% | 2478 |
|
|
2016
Q3 | $77K | Hold |
28,200
| – | – | ﹤0.01% | 2469 |
|
|
2016
Q2 | $81K | Sell |
28,200
-100
| -0.4% | -$287 | ﹤0.01% | 2449 |
|
|
2016
Q1 | $85K | Hold |
28,300
| – | – | ﹤0.01% | 2429 |
|
|
2015
Q4 | $98K | Buy |
28,300
+100
| +0.4% | +$346 | ﹤0.01% | 2427 |
|
|
2015
Q3 | $107K | Hold |
28,200
| – | – | ﹤0.01% | 2397 |
|
|
2015
Q2 | $161K | Hold |
28,200
| – | – | ﹤0.01% | 2391 |
|
|
2015
Q1 | $164K | Buy |
28,200
+13,900
| +97% | +$80.8K | ﹤0.01% | 2394 |
|
|
2014
Q4 | $81K | Hold |
14,300
| – | – | ﹤0.01% | 2486 |
|
|
2014
Q3 | $58K | Hold |
14,300
| – | – | ﹤0.01% | 2509 |
|
|
2014
Q2 | $65K | Buy |
14,300
+2,500
| +21% | +$11.4K | ﹤0.01% | 2498 |
|
|
2014
Q1 | $56K | Hold |
11,800
| – | – | ﹤0.01% | 2474 |
|
|
2013
Q4 | $55K | Buy |
11,800
+1,000
| +9% | +$4.66K | ﹤0.01% | 2451 |
|
|
2013
Q3 | $57K | Hold |
10,800
| – | – | ﹤0.01% | 2426 |
|
|
2013
Q2 | $51K | Buy |
+10,800
| New | +$51K | ﹤0.01% | 2394 |
|